Neutrophil count kinetics during the first cycle of chemotherapy predicts the outcome of patients with locally advanced or metastatic pancreatic cancer.
Giuseppe Antonio CollocaAntonella VenturinoDomenico GuarneriPublished in: Asia-Pacific journal of clinical oncology (2020)
The kinetics of neutrophil count after chemotherapy is an early and independent prognostic factor, which appears to be simple to measure at the start of the second cycle of chemotherapy by means of the neutrophil count growth rate.